Living With Pulmonary Fibrosis: Doctors Offer Hope and Practical Advice

Receiving a diagnosis of a chronic illness like pulmonary fibrosis can be life-altering, introducing medical terms, tests, and treatments. Doctors emphasize that while the diagnosis brings questions about the future and the possibility of living a full life, there is much that can be done. Dr. Sonia Schneier, head of interstitial lung diseases at Carmel Hospital, advises patients to avoid immediate online searches for frightening information and instead consult their pulmonologist for a structured evaluation. This initial phase typically involves assessing lung function, general health, and potentially cardiac function to understand the disease's underlying causes and determine the appropriate treatment path.

Patients are introduced to new terminology such as FVC (forced vital capacity) and DLCO (diffusing capacity of the lungs for carbon monoxide), alongside tests like the six-minute walk test and saturation monitoring. Professor Neville Berkman, director of the lung institute at Hadassah Ein Kerem Hospital, explains that these tests establish a baseline and track disease progression over time. While regular monitoring is crucial, Prof. Berkman cautions against excessive self-monitoring, advising patients to focus on long-term trends rather than momentary fluctuations, as significant lung function can be lost before noticeable symptoms appear.

The treatment landscape for pulmonary fibrosis has significantly evolved over the last decade. Previously, options were limited, but now anti-fibrotic medications like nintedanib and pirfenidone are available to slow disease progression. Dr. Schneier recalls a time when no treatments existed for the condition. While these medications do not reverse existing scarring and may have side effects, adjustments in treatment and management of side effects are possible. The development pipeline is expanding with new therapies under investigation, offering hope for more effective and better-tolerated treatments in the future.

Beyond medication, pulmonary rehabilitation, including guided exercise and breathing techniques, plays a vital role in managing symptoms like shortness of breath and maintaining functional capacity. Prof. Berkman highlights that rehabilitation can significantly improve patients' ability to control their breathing and reduce the sensation of breathlessness. He also addresses the stigma surrounding oxygen use, encouraging patients who need it to use portable oxygen concentrators to maintain an active life, emphasizing that oxygen is essential for organ function and does not lead to dependency.

Optimizing daily life with pulmonary fibrosis also involves tailored nutrition, especially for those experiencing weight loss or treatment side effects, and recommended vaccinations to prevent infections that could worsen the condition. The overarching goal, according to Dr. Schneier, is to enable patients to live full lives, traveling, spending time with family, and engaging in activities, with necessary support like oxygen or rest. While the diagnosis presents challenges, the current medical reality offers more treatment options, monitoring tools, rehabilitation programs, and active research than ever before, allowing individuals to manage the disease without letting it define their entire existence. The "Choff" association also provides support and information to patients and their families.